EMCDDA news

EU4MONITORING DRUGS PROJECT: SPECIAL REPORT AFGHANISTAN 23.11.2020  There are signs that a methamphetamine industry is taking hold in Afghanistan, according to a new report published today by the EU drugs agency (EMCDDA). The paper — Emerging evidence of Afghanistan’s role as a producer and supplier of ephedrine and methamphetamine — explores whether the country, renowned for being the world's leading opium producer, has the potential to become a significant producer of methamphetamine.

Representatives of candidate, potential candidate and neighbouring countries of the EU are joining members of the EMCDDA’s Reitox network this week (23–27 November) for the agency’s ninth Reitox week. The purpose of this annual event is to broaden the scope of the regular Heads of national focal point (NFP) meetings, underline the usefulness of the EU drug monitoring model; add impetus to the agency’s technical cooperation with partners outside the EU and learn from each other’s experience. 23.11.2020 

Scientific Committee elections 20.11.2020  The EMCDDA Scientific Committee has elected its new Chair and Vice-Chair for the period 2020–22. Prof. Dr. Catherine Comiskey (Ireland) was elected to the position of Chair and Prof. Dr. Henri Bergeron (France) to the position of Vice-Chair. The election took place virtually on 13 November at the Committee’s 52nd meeting.

EUROPEAN SCHOOL SURVEY PROJECT ON ALCOHOL AND OTHER DRUGS (ESPAD) 10.11.2020  Smoking and drinking among 15–16-year-old school students are showing signs of decline, but there are concerns over potentially risky cannabis use and the challenges posed by new addictive behaviours. These are among the findings released today in a new report from the European School Survey Project on Alcohol and Other Drugs (ESPAD).